The long noncoding RNA sONE represses triple‐negative breast cancer aggressiveness through inducing the expression of miR‐34a, miR‐15a, miR‐16, and let‐7a RA Youness, HM Hafez, E Khallaf, RA Assal, A Abdel Motaal, MZ Gad Journal of Cellular Physiology 234 (11), 20286-20297, 2019 | 92 | 2019 |
MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc RA Youness, HM El-Tayebi, RA Assal, K Hosny, G Esmat, AI Abdelaziz Oncology Letters 12 (4), 2567-2573, 2016 | 89 | 2016 |
Game changers in science and technology-now and beyond UAK Betz, L Arora, RA Assal, H Azevedo, J Baldwin, MS Becker, ... Technological Forecasting and Social Change 193, 122588, 2023 | 79 | 2023 |
Destabilizing the interplay between miR-1275 and IGF2BPs by Tamarix articulata and quercetin in hepatocellular carcinoma YM Shaalan, H Handoussa, RA Youness, RA Assal, AH El-Khatib, ... Natural Product Research 32 (18), 2217-2220, 2018 | 59 | 2018 |
A novel role of sONE/NOS3/NO signaling cascade in mediating hydrogen sulphide bilateral effects on triple negative breast cancer progression RA Youness, RA Assal, AA Motaal, MZ Gad Nitric oxide 80, 12-23, 2018 | 58 | 2018 |
Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor … RA Youness, MA Rahmoon, RA Assal, AI Gomaa, MT Hamza, I Waked, ... Growth Factors 34 (3-4), 128-140, 2016 | 58 | 2016 |
A methoxylated quercetin glycoside harnesses HCC tumor progression in a TP53/miR-15/miR-16 dependent manner R Ahmed Youness, R Amr Assal, S Mohamed Ezzat, M Zakaria Gad, ... Natural Product Research 34 (10), 1475-1480, 2020 | 52 | 2020 |
An acetylated derivative of vitexin halts MDA-MB-231 cellular progression and improves its immunogenic profile through tuning miR-20a-MICA/B axis AR Awad, RA Youness, M Ibrahim, AA Motaal, HI El-Askary, RA Assal, ... Natural product research 35 (18), 3126-3130, 2021 | 36 | 2021 |
Hindering the synchronization between miR-486-5p and H19 lncRNA by hesperetin halts breast cancer aggressiveness through tuning ICAM-1 RM Abdallah, AM Elkhouly, RA Soliman, N El Mechawy, A El Sebaei, ... Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents) 22 (3), 586-595, 2022 | 33 | 2022 |
Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma HM El Tayebi, AA Waly, RA Assal, KA Hosny, G Esmat, AI Abdelaziz Oncology letters 10 (5), 3206-3212, 2015 | 31 | 2015 |
A pleiotropic effect of the single clustered hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin … RA Assal, HM El Tayebi, KA Hosny, G Esmat, AI Abdelaziz Molecular medicine reports 12 (1), 645-650, 2015 | 27 | 2015 |
miR-744/eNOS/NO axis: A novel target to halt triple negative breast cancer progression FH El Kilany, RA Youness, RA Assal, MZ Gad Breast Disease 40 (3), 161-169, 2021 | 23 | 2021 |
Methylation in MIRLET7A3 gene induces the expression of IGF-II and its mRNA binding proteins IGF2BP-2 and 3 in hepatocellular carcinoma AA Waly, N El-Ekiaby, RA Assal, MM Abdelrahman, KA Hosny, ... Frontiers in Physiology 9, 1918, 2019 | 21 | 2019 |
miRNA-506-3p directly regulates rs10754339 (A/G) in the immune checkpoint protein B7-H4 in breast cancer GS El Din, RA Youness, RA Assal, MZ Gad Microrna 9 (5), 346-353, 2020 | 19 | 2020 |
The association of megalin and cubilin genetic variants with serum levels of 25-hydroxvitamin D and the incidence of acute coronary syndrome in Egyptians: A case control study RA Elsabbagh, MFA Rahman, SI Hassanein, RS Hanafi, RA Assal, ... Journal of Advanced Research 21, 49-56, 2020 | 11 | 2020 |
miR-34a: multiple opposing targets and one destiny in hepatocellular carcinoma RA Yacoub, IO Fawzy, RA Assal, KA Hosny, ARN Zekri, G Esmat, ... Journal of Clinical and Translational Hepatology 4 (4), 300, 2016 | 10 | 2016 |
Understanding the crosstalk between immune cells and the tumor microenvironment in cancer and its implications for immunotherapy NM Elemam, IM Talaat, RA Assal, RA Youness Frontiers in Medicine 10, 1202581, 2023 | 9 | 2023 |
Crosstalk between hesperetin and miR-486-5p in triple-negative breast cancer (TNBC): An approach towards precision medicine RM Abdallah, RA Youness, N El Meckawy, A El Sebaaei, AA Abdelmotaal, ... Annals of Oncology 29, vi28-vi29, 2018 | 9 | 2018 |
Contribution of CYP27B1 and CYP24A1 genetic variations to the incidence of acute coronary syndrome and to vitamin D serum level MS Fam, SI Hassanein, MF Abdel Rahman, RA Assal, RS Hanafi, MZ Gad Canadian Journal of Physiology and Pharmacology 97 (12), 1152-1158, 2019 | 8 | 2019 |
Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies HH Rashwan, AM Taher, HA Hassan, AA Awaji, CJ Kiriacos, RA Assal, ... Pathology-Research and Practice, 155223, 2024 | 6 | 2024 |